Anasetti Claudio
Department of Blood and Marrow Transplantation, University of South Florida, Moffitt Cancer Center, Tampa, Florida, USA.
Best Pract Res Clin Haematol. 2008 Dec;21(4):691-7. doi: 10.1016/j.beha.2008.10.002.
Several recipient and donor risk factors affect outcome after transplantation with allogeneic hematopoietic stem cells. The most important recipient risk factors are patient age, comorbidity, performance status, cytomegalovirus (CMV) status, and disease considerations, such as diagnosis, stage, and cytogenetic risk. Prior chemotherapy regimens, patient race, and IL10 promoter polymorphism also appear to have some impact, but to a lesser extent. The most important donor factor is the level of HLA mismatch. Donor gender, relation, age, and KIR genotype also affect outcome. Donor CMV serology, parity, and race do not appear to affect outcome. These factors must all be considered in relation to one another when selecting whether to recommend patients for transplant.
多个受者和供者风险因素会影响异基因造血干细胞移植后的结果。最重要的受者风险因素包括患者年龄、合并症、体能状态、巨细胞病毒(CMV)状态以及疾病相关因素,如诊断、分期和细胞遗传学风险。既往化疗方案、患者种族和IL10启动子多态性似乎也有一定影响,但程度较小。最重要的供者因素是HLA错配程度。供者性别、亲缘关系、年龄和杀伤细胞免疫球蛋白样受体(KIR)基因型也会影响结果。供者CMV血清学、生育史和种族似乎不影响结果。在决定是否推荐患者进行移植时,必须综合考虑所有这些因素。